Tag: TEVAR
SAVS makes travel scholarship applications call for 2024 meeting
The Southern Association for Vascular Surgery (SAVS) has put out a call for applications from medical students and general surgery residents for 20 travel...
Breaking ground: A trial to improve the care of uncomplicated type...
Because high-quality evidence from large, prospective multicenter trials on the best treatment of uncomplicated type B aortic dissection (uTBAD) is scarce, SVS members Firas...
Study finds no correlation between TEVAR timing and uncomplicated type B...
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective...
NESVS 2022: Study illustrates relationship between increased distance from medical center...
Research detailing that patients traveling farther for complex aortic surgery have higher procedural costs, postoperative imaging costs, and comprehensive one-year costs was among the...
EVS 2022: Study suggests lower rates of aortic rupture, mortality after...
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the...
VEITHsymposium to include world federation session
The World Federation of Vascular Societies (WFVS) is set to hold a session in November during the VEITHsymposium in New York City. The 90-minute session...
No time like the present: The moral imperative for advocacy in...
“I’m so sorry but we have to cancel your surgery”—10 words any warm-blooded surgeon dreads uttering. This time around, it was not for the...
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury...
The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients...
Vascular Specialist@VAM–Conference Edition 2
Featured in this VAM daily edition:
F/BEVAR has high technical success and low mortality in chronic post-dissection TAAA (p. 1 and 3)
Systemic heparin...
Complex TAAA: US ARC IDE registry reports better survival vs. real-world...
Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic...
How an aortic ally can help physicians optimize patient outcomes
This advertorial is sponsored by Gore.
The aorta is special. As one of the most complex and critically important vessels of the vascular system, the...
Study suggests more proximal landing zone is preferred for TEVAR of...
A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection suggests most patients have less than 2cm...
Guidelines recognize potential role for earlier endovascular treatment of uncomplicated type...
New clinical practice guidelines published today aim to act as “guard rails” to determine the treatment options and best practices for managing patients with...
Physicians, industry urged to tackle multifactorial stroke risk following thoracic endovascular...
As evidence builds on the importance of reducing the risk of stroke by removing residual air prior to thoracic endovascular aortic repair (TEVAR) procedures,...
RelayPro thoracic stent graft approved by FDA
Terumo Aortic today (Friday, Aug. 6) announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent-graft system for...
Treo IDE primary endpoint results announced
In the wake of approval by the Food and Drug Administration (FDA) of the Treo abdominal aortic stent-graft system for the treatment of patients...
Journal supplement outlines updated clinical practice guidelines, reporting standards
The Society for Vascular Surgery (SVS) is starting 2021 with updated clinical practice guidelines and reporting standards for three vascular conditions.
Guidelines on chronic mesenteric...
RelayPlus thoracic stent graft post-approval study reports low operative mortality
Terumo Aortic has announced the midterm results from the RelayPlus thoracic stent graft system post-approval study, revealing low operative mortality and morbidity— supporting its...
CX Aortic Vienna reveals preoccupation with radiation reduction, showcases latest CT...
Polling at CX Aortic Vienna points to a high level of vigilance over radiation exposure during endovascular aneurysm repair (EVAR). This was among the...
CX 2020 LIVE aortic arch discussion highlights importance of underlying pathology...
Last week, the CX 2020 LIVE agenda turned to the technically challenging topic of aortic arch interventions. Through presentations, discussion, and polling, the session—chaired...
‘No evidence’ to suggest spinal cord injury is decreased by prophylactic...
MIAMI—Cerebrospinal fluid (CSF) drainage is a key component in the treatment of spinal cord injury but the evidence that prophylactic drainage decreases such injury...
‘Alarming rate’ of severe cerebrospinal fluid drain complications discovered in first-stage...
Severe complications from placement of cerebrospinal fluid drains (CSFD) during first-stage thoracic endovascular aortic repair (TEVAR) and fenestrated-branched endovascular repair (F-BEVAR) of pararenal and...